Home LiteratureArticle Details
PMID: 19252477 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Nature ·Vol. 458 ·No. 7239 ·2009-04-09 ·Pages 771-5

Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K

Abstract

Reprogramming of somatic cells to pluripotency, thereby creating induced pluripotent stem (iPS) cells, promises to transform regenerative medicine. Most instances of direct reprogramming have been achieved by forced expression of defined factors using multiple viral vectors. However, such iPS cells contain a large number of viral vector integrations, any one of which could cause unpredictable genetic dysfunction. Whereas c-Myc is dispensable for reprogramming, complete elimination of the other exogenous factors is also desired because ectopic expression of either Oct4 (also known as Pou5f1) or Klf4 can induce dysplasia. Two transient transfection-reprogramming methods have been published to address this issue. However, the efficiency of both approaches is extremely low, and neither has been applied successfully to human cells so far. Here we show that non-viral transfection of a single multiprotein expression vector, which comprises the coding sequences of c-Myc, Klf4, Oct4 and Sox2 linked with 2A peptides, can reprogram both mouse and human fibroblasts. Moreover, the transgene can be removed once reprogramming has been achieved. iPS cells produced with this non-viral vector show robust expression of pluripotency markers, indicating a reprogrammed state confirmed functionally by in vitro differentiation assays and formation of adult chimaeric mice. When the single-vector reprogramming system was combined with a piggyBac transposon, we succeeded in establishing reprogrammed human cell lines from embryonic fibroblasts with robust expression of pluripotency markers. This system minimizes genome modification in iPS cells and enables complete elimination of exogenous reprogramming factors, efficiently providing iPS cells that are applicable to regenerative medicine, drug screening and the establishment of disease models.

MeSH Terms
Animals Biomarkers/analysis Cell Line Cells, Cultured Cellular Reprogramming/genetics Fibroblasts/cytology Gene Expression Profiling Genetic Vectors/genetics Humans Kruppel-Like Factor 4 Mice Pluripotent Stem Cells/cytology,metabolism Transfection/methods Transgenes/genetics
Chemicals
Biomarkers KLF4 protein, human Klf4 protein, mouse Kruppel-Like Factor 4
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kaji Keisuke
MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, University of Edinburgh, Edinburgh EH9 3JQ, UK. keisuke.kaji@ed.ac.uk
Norrby Katherine
Paca Agnieszka
Mileikovsky Maria
Mohseni Paria
Woltjen Knut
References (27)
27 references, click to expand
  1. c-Myc is dispensable for direct reprogramming of mouse fibroblasts.
    Cell Stem Cell. 2008 Jan 10;2(1):10-2 PMID: 18371415
  2. Reprogramming of murine and human somatic cells using a single polycistronic vector.
    Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):157-62 PMID: 19109433
  3. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.
    Oncogene. 2005 Feb 24;24(9):1491-500 PMID: 15674344
  4. Efficient selection for high-expression transfectants with a novel eukaryotic vector.
    Gene. 1991 Dec 15;108(2):193-9 PMID: 1660837
  5. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.
    Cell. 2005 May 6;121(3):465-77 PMID: 15882627
  6. Chromosomal transposition of PiggyBac in mouse embryonic stem cells.
    Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9290-5 PMID: 18579772
  7. Generation of pluripotent stem cells from adult mouse liver and stomach cells.
    Science. 2008 Aug 1;321(5889):699-702 PMID: 18276851
  8. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
    Nat Cell Biol. 2004 Apr;6(4):308-18 PMID: 15048125
  9. Induced pluripotent stem cells generated without viral integration.
    Science. 2008 Nov 7;322(5903):945-9 PMID: 18818365
  10. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture.
    Nat Biotechnol. 2003 Feb;21(2):183-6 PMID: 12524553
  11. Nanog safeguards pluripotency and mediates germline development.
    Nature. 2007 Dec 20;450(7173):1230-4 PMID: 18097409
  12. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette.
    Stem Cells. 2009 Mar;27(3):543-9 PMID: 19096035
  13. Induced pluripotent stem cell lines derived from human somatic cells.
    Science. 2007 Dec 21;318(5858):1917-20 PMID: 18029452
  14. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.
    Nat Biotechnol. 2004 May;22(5):589-94 PMID: 15064769
  15. Generation of germline-competent induced pluripotent stem cells.
    Nature. 2007 Jul 19;448(7151):313-7 PMID: 17554338
  16. Reprogramming of human somatic cells to pluripotency with defined factors.
    Nature. 2008 Jan 10;451(7175):141-6 PMID: 18157115
  17. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  18. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.
    Cell Stem Cell. 2007 Jun 7;1(1):55-70 PMID: 18371336
  19. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nat Biotechnol. 2008 Jan;26(1):101-6 PMID: 18059259
  20. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
    Nature. 2007 Jul 19;448(7151):318-24 PMID: 17554336
  21. DNA methyltransferase inhibitors for cancer therapy.
    Cancer J. 2007 Jan-Feb;13(1):17-22 PMID: 17464242
  22. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment.
    Development. 2007 Aug;134(16):2895-902 PMID: 17660198
  23. Efficient multicistronic expression of a transgene in human embryonic stem cells.
    Stem Cells. 2007 Jul;25(7):1707-12 PMID: 17395772
  24. Generation of mouse induced pluripotent stem cells without viral vectors.
    Science. 2008 Nov 7;322(5903):949-53 PMID: 18845712
  25. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
  26. Dissecting direct reprogramming through integrative genomic analysis.
    Nature. 2008 Jul 3;454(7200):49-55 PMID: 18509334
  27. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells.
    Nat Cell Biol. 2006 Mar;8(3):285-92 PMID: 16462733
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2009-04-09
Epub
2009-00-01
Pages
771-5
Language
English
Region
England
NLM ID
0410462
PMCID
PMC2667910
Subset
IM
Grants
Medical Research Council · G0700672 · United Kingdom
Medical Research Council · G0700672(82649) · United Kingdom
Biotechnology and Biological Sciences Research Council · United Kingdom
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com